# Andrew Alliance

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/andrew-alliance-s-a

- Industry: Consumer Products
- Headquarters: Geneva, Switzerland
- Website: www.andrewalliance.com
- Total disclosed funding: $14M
- Latest round: Series C (Jun 12, 2018)
- Investors on record: 6

## About

Andrew Alliance S.A. focuses on developing advanced liquid handling solutions, enhancing laboratory efficiency through automation, and providing innovative software solutions for researchers and scientists worldwide.Founded in 2011 and headquartered in Geneva, Switzerland, Andrew Alliance S.A. specializes in liquid handling automation. The company has received a Series C funding round of USD 14.00 mn, raising a total of USD 14.00 mn. Their most recent deal occurred on January 13, 2020. Notably, Andrew Alliance S.A. entered into a definitive agreement to acquire Waters Corporation; financial terms were undisclosed. The company has completed three deals to date.Andrew Alliance specializes in advanced liquid handling solutions, primarily through its flagship product, the Andrew+ pipetting robot. This innovative liquid handling robot enhances laboratory workflows by automating the use of conventional pipettes and labware, ensuring reproducible and fully traceable experiments. Additionally, the company offers OneLab Software, a unique and free web-based application that allows scientists to design and execute laboratory protocols effectively, thus improving productivity and reproducibility while reducing workload. Andrew Alliance's clients primarily include researchers and scientists in biopharmaceuticals, environmental sciences, and food safety, indicating a broad customer base that spans academic institutions, pharmaceutical companies, and private research facilities in North America, Europe, and Asia-Pacific regions.Revenue generation for Andrew Alliance is driven by the sale of its automated liquid handling products and subscription services associated with its software solutions. The company implements a business-to-business (B2B) model, partnering with research institutions and laboratories that require efficient liquid handling capabilities. Transactions typically involve the purchase of products such as the Andrew+ pipetting robot and associated devices, along with ongoing subscriptions for software updates and support. Pricing structures are designed to accommodate various client needs, allowing for scalable solutions tailored to specific laboratory requirements. This strategic approach emphasizes Andrew Alliance's commitment to enhancing lab automation while fostering long-term partnerships with its clientele.Andrew Alliance S.A. aims to expand its product offerings and enhance its market presence following its recent acquisition of Waters Corporation. The funding from the Series C round will support the development of upcoming products and targeted expansions into new markets across Europe and Asia by 2022.

## Funding rounds

- Series C, Jun 12, 2018, $14M — Waters Corporation, Tecan Group AG, Omega Funds, Rancilio Cube, Sam Eletr Trust, Inpeco
- Series B, Aug 5, 2014 — Omega Funds

## Investors

- Omega Funds (https://capitalatlas.ai/funds/omega-funds) — Series B, Series C
- Waters Corporation — Series C
- Tecan Group AG — Series C
- Rancilio Cube (https://capitalatlas.ai/funds/rancilio-cube) — Series C
- Sam Eletr Trust — Series C
- Inpeco — Series C